There is strong evidence to implicate transforming growth factor-␤ of collagen I and fibronectin, which leads to increased protein in the remodeling that occurs in asthma, as levels are increased in production in human lung fibroblasts (7) and vascular smooth bronchial lavage fluid and gene expression is increased in bronchial muscle cells (8).
In asthma, it has been reported that the concentration of TGF-␤ in bronchial lavage fluid is higher than in normal Airway wall remodeling is one of the key features of asthma.
control subjects (12), and TGF-␤ gene expression has been The extracellular matrix provides the mechanical support observed to be increased in bronchial tissue from subjects required for airway structure and function but also has the with asthma (16-18). Increased immunoreactivity for TGF-␤ potential to influence a variety of functions of the embedded cells, including migration, proliferation, and differentiation has been demonstrated in bronchial biopsies and submucosal (1, 2) . Part of the remodeling process involves the alteration eosinophils from subjects with asthma (16, 18). Many of the of the local composition of the extracellular matrix within observed effects of TGF-␤ in injury and fibrosis, such as cell the airways. In asthmatic airways, the deposition of collagen proliferation, migration to site of injury, and extracellular I, III, and V, fibronectin, tenascin, hyaluronan, versican, and matrix synthesis, have been shown to be mediated via CTGF laminin ␣2 and ␤2 are reported to be increased, whereas (9, 19, 20) . The possibility that the TGF-␤-mediated airway collagen IV and elastin are decreased (3) (4) (5) . The underlying remodeling effects may be occurring via CTGF has not been mechanisms resulting in the altered extracellular matrix deexamined previously. In this study, we tested the hypothesis position are currently not well understood.
that TGF-␤ might induce CTGF expression and release in One protein that has been suggested to play a role in the human airway smooth muscle cells and compared the effects extracellular matrix remodeling that occurs during fibrosis of TGF-␤ in asthmatic and nonasthmatic airway smooth musand scarring is connective tissue growth factor (CTGF).
cle cells. CTGF is a cysteine-rich 38-kD protein that was originally identified as a growth factor secreted by human umbilical METHODS vein endothelial cells (6). CTGF upregulates gene expression the online supplement. Data from the reaction were collected and copy, and asthmatic airway smooth muscle was obtained from one analyzed by the complementary computer software (26). lung donation, one patient dying in status asthmaticus, and four deep endobronchial biopsies by methods previously described (21) (22) (23) (24) . The Immunohistochemistry details about the patients are shown in Table 1 . Approval for all experiWe performed immunohistochemistry to detect the presence of CTGF ments with human lung was provided by the Human Ethics Committee on human airway smooth muscle cells grown on glass coverslips for 5 of the University of Sydney and the Central Sydney Area Health Serdays in 10% FBS DMEM followed by 24 hours with or without TGF-␤ vice, and all patients provided written informed consent. Airway smooth (1 ng/ml) as described previously (27) . CTGF was detected using the muscle cell characteristics were determined by immunofluorescence rabbit polyclonal antibody raised against mouse CTGF (CTGF-ab6992) and light microscopy (25).
with cross-reactivity to human CTGF followed by the goat anti-rabbit horseradish peroxidase-conjugated secondary antibody. Hoechst was Stimulation with TGF-␤ used to stain the nuclei of all cells present on the coverslip. Airway smooth muscle cells were seeded in six-well plates at 1 ϫ 10 4 cells/cm 2 in 5% FBS DMEM for 24 hours before being synchronized Western Blot for 24 hours in 0.1% ITS in DMEM. For stimulation, TGF-␤ (1 ng/ml) Cellular proteins were size fractionated on 10% polyacrylamide gels, or PDGF (10 ng/ml) was added to the cells for 15 minutes to 24 hours. To transferred to polyvinylidene difluoride membranes, and blocked overconfirm the role of TGF-␤, we performed experiments in the presence of night in 5% (wt/vol) skim milk solution as described previously (23). a neutralizing anti-TGF-␤ antibody (1.2 ng/ml). Control cells were main-
The membranes were incubated with a rabbit polyclonal anti-CTGF tained in 0.1% ITS in DMEM. At the completion of each incubation, antibody (1 in 5,000 in skim milk solution) for 1 hour before washing cells were washed in ice-cold phosphate-buffered saline and kept on ice and incubation with secondary antibody (1 in 40,000 in skim milk soluuntil lysis in protein extraction buffer (20 mM Tris, pH 7.4, 1 mM ethtion) for 1 hour. Immunoblot detection was performed using a supersigylenediaminetetraacetic acid, 1 mM benzamidine, 1 mM PMSF, 1 mM nal west dura extended duration substrate kit (Pierce, Rockford, IL), Aprotinin, and 10% Triton X-100). Cells were scraped from the culture and bands were analyzed using a 440F Kodak imaging system and softwells with multiple pipetting and then stored at Ϫ20ЊC until analysis.
ware. Cells for RNA analysis were lyzed and stored at Ϫ20ЊC until extraction. Total RNA was extracted from airway smooth muscle cells using the Statistical Analysis RNeasy Mini Kit (Qiagen, Clifton Hill, Australia) according to the manufacturer's instruction. After extraction, samples were eluted in 30-L In real-time PCR experiments, the number of cycles needed to attain RNase-free water and stored at Ϫ20ЊC until use. a threshold fluorescence set to lie on the exponential part of the amplification plot was determined. Results for CTGF were normalized against Laser Capture Microdissection those obtained for 18S and were expressed as a cycle difference (basal Nonasthmatic lung tissue containing bronchial segments was mounted levels) or a fold increase (TGF-␤ stimulated). Results from triplicate wells in optimum cutting temperature compound (OCT) (Miles, Elkhart, IN) from each individual patient were meaned, and an overall mean and and snap frozen in liquid nitrogen-cooled isopentane before storage SEM were calculated for cycle number. Analysis of variance using reat Ϫ80ЊC. The tissues were brought to Ϫ20ЊC and 5-to 6-m sections peated measures and the Fisher protected least square differences cut before being placed on plain glass slides at room temperature and (PLSD) post-test was performed on the results for real-time RT-PCR immediately fixed. Sections were prepared for laser capture microdisand mean densitometric values for Western blots. Factorial analysis of section. Additional detail on the preparation of the sections is provided variance was used to compare CTGF mRNA and protein production in the online supplement. Airway smooth muscle bundles were captured curves generated from asthmatic and nonasthmatic cells. In all cases, onto the CapSure High Sensitivity LCM caps and stored at Ϫ70ЊC in a p value of less than 0.05 was considered significant. the presence of 10 to 20 L lysis buffer until RNA was isolated using the Total RNA Microprep kit (Stratagene, La Jolla, CA) according to Taqman primers and probe were used with 100-ng total RNA isolated from nonasthmatic airway smooth muscle cells in culture grown in 5% FBS in DMEM for 7 days (squares) or total RNA isolated from 1,000 airway smooth muscle cells obtained from a nonasthmatic lung section using laser capture microdissection (Xs). ⌬Rn represents the changes in fluorescence. The graph is representative of the results seen in three separate experiments.
from lung sections obtained from three individuals, and subsequent amplification of the CTGF mRNA by real-time RT-PCR demonstrated that the CTGF mRNA was present in airway smooth muscle in the lung. A representative graph of RNA from both captured and cultured nonasthmatic airway smooth muscle cells is shown in Figure 1 .
Detection of CTGF Protein in Airway Smooth Muscle
To determine whether CTGF protein was detectable, airway smooth muscle cells were grown on glass coverslips for immunohistochemistry. Cells were stained with the secondary antibody alone as the fluorescence control (Figure 2A ). The level of fluorescence in unstimulated airway smooth muscle cells was above the background level of fluorescence, indicating the presence of CTGF in these cells ( Figure 2B ). As TGF-␤ has been reported to induce upregulation of CTGF in other cell types, we investigated the effect of this growth factor on CTGF in airway smooth muscle cells. After the airway smooth muscle cells had been stimulated with TGF-␤ for 24 hours, there was a significant increase in the level of fluorescence detected ( Figure 2C ). The staining was not located in the nuclear compartments of the cells but rather was in the cytoplasmic regions.
Stimulation of CTGF mRNA with TGF-␤
TGF-␤ has been reported to induce upregulation of CTGF mRNA in fibroblasts and vascular smooth muscle cells, and thus, we determined the effect of this growth factor on CTGF mRNA in airway smooth muscle cells. To avoid the influence of serum induction of CTGF expression, the experiments were performed in DMEM supplemented with 0.1% ITS over a 24-hour time course, and the induction of CTGF gene expression by 0.1% the asthmatic or the nonasthmatic cells ( Figure 5A ).
respectively) compared with the expression observed at time 0. muscle cells, which is consistent with findings in other cell types (9, 31), viz that the induction of CTGF is specific to TGF-␤. Overall, the asthmatic cells showed a significantly greater reAs is true for fibroblasts, the TGF-␤-mediated effects in sponse to TGF-␤ than the nonasthmatic cells (p Ͻ 0.03) (Figure airway smooth muscle could be occurring via CTGF. Cohen and 5B). When the TGF-␤ was preincubated with a neutralizing colleagues recently reported that insulin growth factor binding TGF-␤ antibody, the TGF-␤-mediated induction of CTGF proprotein 3 (IGFBP3)-mediated TGF-␤-induced airway smooth tein expression was markedly downregulated in both the asthmuscle cell growth (14) . They observed an increase in IGFBP3 matic (28.76 Ϯ 14.4% TGF-␤ response, p Ͻ 0.05) and the nonmRNA 24 hours after stimulation with TGF-␤, and observed asthmatic cells (25.05 Ϯ 7.91% TGF-␤ response, p Ͻ 0.01) at an enhanced release of IGFBP3 from the airway smooth muscle 24 hours ( Figure 5C ). PDGF did not stimulate an increase in 72 hours after TGF-␤ stimulation; however, they did not deterthe level of CTGF protein in either the asthmatic or the nonasthmine whether the increase in IGFBP3 mRNA was dependent on matic cells, with the small response seen in the asthmatic cells the de novo synthesis of mRNA, prolonged survival of mRNA, or not reaching significance (data not shown). enhanced translation. It is possible that CTGF is also contributing to this TGF-␤-mediated cell growth in airway smooth muscle.
DISCUSSION
CTGF could be an upstream event involved in the signaling This is the first study to identify human airway smooth muscle process leading to increased IGFBP3 mRNA and protein, as we cells as a source for CTGF mRNA and protein. We have shown observed the increases in CTGF much earlier (mRNA by 8 hours the CTGF protein in airway smooth muscle is specifically inducand the protein was significantly increased by 24 hours after ible by TGF-␤ and is not induced by PDGF. In addition, we TGF-␤ stimulation) than the increases reported for IGFBP3. report for the first time an increase in CTGF mRNA and protein Alternatively, the CTGF-mediated effects could be acting independently of the IGFBP3 events. expression in asthmatic airway smooth muscle compared with TGF-␤ induces an autocrine increase in the synthesis of collanonasthmatic airway smooth muscle.
gen I in bovine airway smooth muscle cells (11). As CTGF has A significant induction of CTGF mRNA synthesis after been reported to increase collagen ␣I mRNA and protein release TGF-␤ stimulation of the airway smooth muscle cells was obfrom fibroblasts (7), the TGF-␤-mediated increase in collagen served after 8 hours. The fold change in expression of CTGF I in airway smooth muscle could also be mediated via CTGF. message was significantly greater in the asthmatic cells than
The upregulation of CTGF in airway smooth muscle cells may in the nonasthmatic cells. The maximal expression of mRNA also be involved in controlling the expression of fibronectin (as occurred somewhere between 8 and 24 hours. The asthmatic seen in fibroblasts [7] and vascular smooth muscle cells [8]), and cells showed greatest expression at 8 hours, but the nonasthmatic other extracellular matrix proteins that have yet to be examined. cells were still increasing in mRNA synthesis at 24 hours, indicat-CTGF has recently been shown to increase the activity of matrix ing that asthmatic airway smooth muscle cells may have a shortmetalloproteinase 2 by altering the mRNA level of matrix metalened or more sensitive TGF-␤ signaling cascade or may express loproteinase 2 in vascular smooth muscle cells (33) . Under physihigher numbers of TGF-␤ receptors.
ologic conditions, the expression of matrix metalloproteinases The level of protein expression detected was maximal in both and their specific inhibitors, the tissue inhibitors of metalloprocell types at 24 hours. It is possible that the protein levels may teinases, is highly coordinated at the level of gene expression continue to increase beyond the 24-hour time point, which was (34) . This balanced expression guarantees normal tissue structhe last time point in this study. There is a possibility that a gene ture and organ function and prevents both excessive extracellular can be activated during culture, and our finding of the presence matrix deposition and increased extracellular matrix degradaof CTGF may have represented a culture artifact. To control tion. In the lung, distortion of this balance is associated with for this, we captured airway smooth muscle cells from sections various inflammatory lung diseases and lung cancer (35, 36) . of nonasthmatic lung and indeed found that CTGF was present
We have previously shown that the profile of extracellular in isolated muscle bundles. This demonstrates that the CTGF matrix proteins released from nonasthmatic cells can be modified gene is expressed in this specific cell type in the human lung, by the allergic process (37). In addition, we have demonstrated and this raises the possibility that it may contribute to the lung that the asthmatic airway smooth muscle cells release a different structure.
profile of extracellular matrix proteins compared with nonasth-TGF-␤ is a multifunctional protein that is one of the most matic airway smooth muscle cells (38). The differential exprespotent regulators of inflammation and connective tissue synthesion and the faster induction of CTGF observed in the asthmatic sis (28) . It has previously been demonstrated to induce fibrocells in this study could play a key role in the regulation, producblasts, in culture, to proliferate, and to synthesize extracellular tion, and degradation of the different extracellular matrix promatrix proteins such as collagen ␣1, fibronectin, and proteoglyteins released by asthmatic airway smooth muscle cells. cans (29, 30) . TGF-␤ also induces proliferation and collagen ␣1 TGF-␤ is increased in the bronchoalveolar lavage fluid of release from airway smooth muscle cells in vitro (10, 11, 14, 15) .
patients with asthma compared with normal control subjects, Many of the mitogenic and extracellular matrix synthesisand the levels of TGF-␤ were further increased in the patients promoting effects of TGF-␤ on connective tissue cells are mimwith asthma after an allergen challenge (12). In addition, increased icked by CTGF (6, 31, 32), but the presence of this growth factor TGF-␤1 gene expression has been found in submucosal eosinoin airway smooth muscle cells has not been examined previously.
phils from asthmatic airways (16, 17), and increased immunoIn the airway smooth muscle cells, the levels of CTGF, in reactivity was observed in biopsies from asthmatics and chronic response to TGF-␤ stimulation, were markedly decreased when bronchitic individuals compared with control individuals (18). cells were preincubated with an anti-TGF-␤ antibody. The small Together with our results in the current study, it can be assumed response seen in the presence of the antibody may be due to that these increases in the level of TGF-␤ present in the asthmatic the fact that we did not achieve a stoichiometric balance between airways would lead to further induction of CTGF expression. the antibody and the TGF-␤ concentrations.
Whether this would lead to the presence of CTGF protein in Only a small increase in CTGF mRNA synthesis in response human airways is not known. to PDGF was observed in the airway smooth muscle cells, but
Our study supports this hypothesis by demonstrating significantly increased production of CTGF mRNA and protein in this was not reflected at the protein level in the airway smooth 
